New developments in the treatment of chemotherapy-induced neutropenia: focus on balugrastim

Neutropenia and febrile neutropenia are two major complications of chemotherapy. Dose reductions, delays in treatment administration, and the use of granulocyte colony-stimulating factors are equally recommended options to preserve absolute neutrophil count in case of chemotherapy regimens bringing...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghidini, Michele, Hahne, Jens Claus, Trevisani, Francesco, Panni, Stefano, Ratti, Margherita, Toppo, Laura, Tomasello, Gianluca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928625/
https://www.ncbi.nlm.nih.gov/pubmed/27445479
http://dx.doi.org/10.2147/TCRM.S80732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928625/
https://www.ncbi.nlm.nih.gov/pubmed/27445479
http://dx.doi.org/10.2147/TCRM.S80732

Ejemplares similares